{"entity":{"id":"nct01117441","kind":"trial","name":"International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia","aka":[],"tldr":"A phase 3 trial of Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Doxorubicin, Etoposide, Ifosfamide, Mercaptopurine, Methotrexate, Prednisone, Thioguanine, Vincristine, Vindesine and Fludarabine in Leukaemia, run by University Hospital Schleswig-Holstein, completed.","summary":"International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia is a phase 3 interventional study registered as NCT01117441 by University Hospital Schleswig-Holstein, with 6136 participants recorded, started 2010-06 and reaching its primary completion in 2021-12-31. Interventions recorded: PEG-L-asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate, vindesine, daunoxome, fludarabine, Radiation Therapy. Conditions recorded: Leukemia.\n\nLinked to the drug Vindesine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01117441","url":"https://clinicaltrials.gov/study/NCT01117441"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["leukaemia"],"sections":[],"technologies":[],"targets":[],"drugs":["cyclophosphamide","cytarabine","daunorubicin","dexamethasone","doxorubicin","etoposide","ifosfamide","mercaptopurine","methotrexate","prednisone","thioguanine","vincristine","vindesine","fludarabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01117441","phase":"3","setting":"International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia","sponsor":"University Hospital Schleswig-Holstein","enrolled":6136,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01117441/","neighbours":{"cancer":[{"id":"leukaemia","kind":"cancer","name":"Leukaemia (all types)","route":"/cancers/leukaemia/"}],"drug":[{"id":"cyclophosphamide","kind":"drug","name":"Cyclophosphamide","route":"/drugs/cyclophosphamide/"},{"id":"cytarabine","kind":"drug","name":"Cytarabine","route":"/drugs/cytarabine/"},{"id":"daunorubicin","kind":"drug","name":"Daunorubicin","route":"/drugs/daunorubicin/"},{"id":"dexamethasone","kind":"drug","name":"Dexamethasone","route":"/drugs/dexamethasone/"},{"id":"doxorubicin","kind":"drug","name":"Doxorubicin","route":"/drugs/doxorubicin/"},{"id":"etoposide","kind":"drug","name":"Etoposide","route":"/drugs/etoposide/"},{"id":"fludarabine","kind":"drug","name":"Fludarabine","route":"/drugs/fludarabine/"},{"id":"ifosfamide","kind":"drug","name":"Ifosfamide","route":"/drugs/ifosfamide/"},{"id":"mercaptopurine","kind":"drug","name":"Mercaptopurine","route":"/drugs/mercaptopurine/"},{"id":"methotrexate","kind":"drug","name":"Methotrexate","route":"/drugs/methotrexate/"},{"id":"prednisone","kind":"drug","name":"Prednisone","route":"/drugs/prednisone/"},{"id":"thioguanine","kind":"drug","name":"Thioguanine","route":"/drugs/thioguanine/"},{"id":"vincristine","kind":"drug","name":"Vincristine","route":"/drugs/vincristine/"},{"id":"vindesine","kind":"drug","name":"Vindesine","route":"/drugs/vindesine/"}]}}